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Studies have reported the association of the COL1A1 Sp1 binding site variant (rs1800012) with the risk of acute 
musculoskeletal soft tissue injuries. Inter- action with the COL1A1 promoter variant (rs1107946) has also been 
proposed to modulate acute injury risk. Conversely, neither of these loci have been associated with chronic 
musculoskeletal soft tissue phenotypes. Therefore, the primary aim of this study involved characterizing these 
variants in a cohort of participants with chronic Achilles tendinopathy. Second, this study aimed to support the 
contribution of the rs1107946 and rs1800012 variants to the profile predisposing for acute musculoskeletal soft 
tissue injuries including Achilles tendon and anterior cruciate ligament (ACL) ruptures. A hypothesis‐ driven 
association study was conducted. In total, 295 control participants, 210 participants with clinically diagnosed 
Achilles tendinopathy, and 72 parti- cipants with Achilles tendon ruptures recruited independently from South 
Africa and the United Kingdom were genotyped for the prioritized variants. In addition, a cohort including 232 
control participants and 234 participants with surgically diagnosed ACL ruptures was also analyzed. Although no 
associations were observed in the recruited cohorts, the rare rs1800012 TT genotype was associated with 
decreased ACL injury risk when the results from the current study were combined with that from previously 
published studies (P = .040, OR: 2.8, 95% CI: 1.0‐11.0). In addition, the G‐T (rs1107946‐rs1800012) inferred 
haplotype was associated with decreased risk for Achilles tendon ruptures. These results support previous 
observations and reiterate the heterogeneity of musculoskeletal phenlotypes whereby certain markers may be 





Emerging research suggests that regular exercise is associated with well‐being, promoting longevity delaying 
disease onset and improving the overall quality of life.1 However, paralleled with the increase in physical activity is 
the adverse increase in the incidence of associated injuries such as musculoskeletal injuries.2 Approximately, 30%‐
50% of all sports‐related musculoskeletal soft tissue injuries affect tendons and ligaments,3 with the incidence of 
these injuries remaining high despite increased injury awareness and some advances in preventative strategies.4,5 
Type I collagen is the major fibrillar collagen found in tendons and ligaments.6 This heterotrimer molecule consists 
of two α1‐ and one α2‐ chains encoded by the COL1A1 (chr17q21.33) and COL1A2 (chr7q21.3) genes, respectively. 
Several COL1A1 mutations have been associated with severe musculoskeletal disorders including osteogenesis 
imperfecta   and   Ehlers‐Danlos   syndrome.7,8   Moreover,   several independent studies have demonstrated the 
association of two func- tional variants within the COL1A1 gene (rs1107946 and rs1800012) with the risk of acute 
sports‐related musculoskeletal soft tissue injuries including shoulder dislocations and cruciate ligament (CL) and 
Achilles tendon ruptures (ATR) (Table 1).9‐14 Conversely, two studies investigating the possible association of these 
variants with the risk of chronic musculoskeletal soft tissue injuries including Achilles tendino- pathy (TEN) and 
tennis elbow have failed to demonstrate similar associations (Table 1).15,16 These results suggest that there are 
important differences in the genetic profiles predisposing for muscu- loskeletal soft tissue injuries, whereby, some 
loci may be common to both chronic and acute injuries, while other loci may be unique. 
 
Therefore, this study aimed to test this hypothesis by repeating the association of the COL1A1 rs1107946 (G>T) and 
rs1800012 (G>T) variants with the risk of ACL rupture in a cohort of self‐ identified white individuals. In addition, 
the potential contribution of these variants to the genetic profile predisposing for acute Achilles tendon injuries and 
chronic Achilles TEN was explored. The final aim involved conducting combined statistical analyses, in which the 








This study followed a case‐control genetic association study approach (level of evidence III). Three cohorts, which 
included banked DNA samples and information of ancestry matched control and case participants, were used for 
this study. All recruited participants self‐identified as being of white European ancestry. The two cohorts’ 
representative of Achilles tendon injuries were sampled independently from South Africa (SA) and the United 
Kingdom (UK) and were subsequently pooled to increase the statistical power of the study. The SA‐Achilles tendon 
injury cohort consisted of 165 apparently healthy asymptomatic control participants (SA‐CONAT), 123 participants 
with chronic Achilles SA‐TEN and 47 participants with acute SA‐ATR.22,23 It must be noted that the rs1800012 
variant was previously genotyped in the SA‐Achilles tendon injury cohort and the result presented by Posthumus et 
al.15 For this reason, this data was only included for the combined analyses. The UK‐Achilles tendon injury cohort 
consisted of 130 apparently healthy asymptomatic control participants (UK‐CON), 87 participants with chronic 
Achilles UK‐TEN and 25 participants with acute UK‐ATR.24 The single ACL rupture cohort consisted of 232 ap- 
parently healthy asymptomatic control participants (SA‐CONACL) and 
233 participants with clinically diagnosed ACL ruptures (SA‐ACL). Moreover, 135 participants reported a noncontact 
mechanism of injury (SA‐NON).10,25  Similar  to  the  participants  in  the  SA‐Achilles  tendon injury cohort who 
were previously genotyped for the specificity‐1 (Sp1) binding site variant, 130 SA‐CONACL and 117 SA‐ACL 
participants were genotyped for rs1800012 in the SA‐ACL rupture cohort and the results presented by Posthumus 
et al.10 Since publication of this initial manuscript, an additional 102 controls and 115 cases were recruited and 
analyzed in this study. 
 
The control participants within the SA cohorts were recruited from various sports clubs and gyms around the 
greater Cape Town area. Case participants were recruited from the Sports Science Orthopaedic Clinic at the Sports 
Science Institute of South Africa and other clinical practices in Cape Town between 2004 and 2016. Control 
 
participants in the UK‐Achilles tendon injury cohort were recruited from the East Midlands region of the UK, 
whereas affected individuals were recruited from The County Clinic in Northampton, UK (2011‐2014). Participants 
were included in the study based on the inclusion and exclusion criteria as first presented by Mokone et al23 and 
Posthumus et al.26 All participants provided written informed consent in accordance with the Declaration of 
Helsinki and completed questionnaires detailing their personal particulars and medical and sporting histories. This 
study was approved by the Human Research Ethics Committee (159/2011, 164/2006, and 370/2013) and the review 





Through venepuncture of the forearm vein, each participant in the SA‐Achilles tendon injury and ACL rupture 
cohorts provided approximately 5 mm of venous blood, which was collected in an ethylenediaminetetraacetic acid 
vacutainer tube. The blood samples were stored at −20°C until the total DNA extraction was performed using the 
protocol described by Lahiri and Nurnberger27 and later modified by Mokone et al.23 Approximately, 2 mm of 
saliva was collected from each participant in the British cohort using the OrageneTM OG‐500 DNA collection tubes. 
Participant DNA was subsequently extracted using the prepIT DNA extraction kit (DNA Genotek Inc, Ontario, 
Canada) as previously described by Rickaby et al.24 Samples yielded A260/A280 ratios between 1.8 and 2.0. With 
reference to the UK‐cohort, all DNA extractions were conducted at the University of Northampton (UK). 
 
 
SNP selection and genotyping 
 
The two functional COL1A1 variants, rs1107946 (G>T) and rs1800012 (G>T), previously associated with the risk of 
musculoskeletal soft tissue injuries were prioritized for genotyping in the independent cohorts. The rs1107946 
variant maps to the distal promoter region of the gene, 1997 bp upstream from the transcription start site. The 
rs1800012 variant locates 1245 bp downstream of the transcription start site within intron one and overlaps the 
binding site of the Sp1 transcription factor (Figure 1). 
All participants were genotyped for the selected COL1A1 variants using inventoried Taqman genotyping assays 
(Applied Biosystems, Foster City, CA). The polymerase chain reaction (PCR) reactions were performed using the 
Applied Biosystems StepOnePlus and QuantStudio 3 Real‐Time PCR systems (Applied Biosystems) following the 
manufacturer's recommendations. For quality control purposes, negative (DNA‐free) and positive controls (samples 
of known genotype) were included in each 96‐well PCR plate during the genotyping process. Two investigators 
confirmed genotype calls with all laboratory work conducted at the Division of Exercise Science and Sports 
Medicine at the University of Cape Town. This study was conducted in accordance with the recommendations of 





The QUANTO v1.2.4 software (http://biostats.usc.edu/software) was used to determine the statistical power of all 
analyses based on the respective sample sizes. Assuming “risk” allele frequencies between 0.2 and 0.8, a sample 
size of 100 cases and 200 controls would be sufficient to detect an allelic odds ratio of ≥2.0 at a power of 80% and a 
significance level of 5%. All statistical analyses were conducted in the R programming environment using specific R 
packages.29 Quantitative variables were expressed as means and standard deviations, whereas qualitative 
characteristics were presented as frequencies. One‐way analysis of variance was used to determine characteristic 
differences between the diagnostic groups and the possible genotype effects on age, sex, body mass, height, and 
body mass index (BMI). The Genetics and SNPassoc packages were used to determine genotype and allele 
frequencies, in addition to Hardy‐Weinberg equilibrium (HWE) probabilities.30,31 HWE P values are provided as 
exact P values. Logistic regression models testing the association of gene variants with the risk of musculoskeletal 
soft tissue injuries were adjusted for potential nongenetic confounders. Confounding parameters were equally 
weighted in the logistic regression models and entered by means of a forward method. In the instance when the 
genotype categories demonstrated frequencies less than 10%, a Fisher's exact test was conducted. The haplo.stats 
package was used to test the association between inferred haplotypes and the risk of musculoskeletal soft tissue 
 
injury.32 The strength of the association is reflected by the score statistic (Haplo.score). Negative values infer 
decreased risk, while positive scores infer an increased risk for injury. Statistical significance was accepted when P < 
.05. Adjustments for multiple testing were not performed on the genotype data as there is existing evidence for the 
association of both investigated COL1A1 variants with the risk of musculoskeletal soft tissue injuries.9,10,14 
Therefore, this study followed an evidence‐based hypothesis approach and not a hypothesis‐free approach in which 







The participants in the SA‐Achilles tendon injury cohort were matched for sex, height, and country of birth (Table 
S1). However, The SA‐CONAT participants were significantly younger at the time of re- cruitment (36.5 ± 10.9 years) 
compared to the age of participants in the SA‐TEN (41.5 ± 14.0 years; P = .002) and SA‐ATR (40.4 ± 11.9 years; P = 
.038) groups at the time of injury. In addition, the SA‐CONAT participants weighed significantly less at the time of 
recruitment (72.1 ± 11.9 kg) compared to the SA‐TEN (78.6 ± 17.5 kg; P < .001) and SA‐ATR (86.0 ± 15.3 kg; P < 
.001). Consequently, the BMI of the SA‐CONAT group (23.5 ± 2.8 kg/m2) was significantly lower than that of the SA‐
TEN (24.8 ± 3.3 kg/m2; P = .002) and SA‐ATR (27.8 ± 4.0 kg/m2; P < .001) groups. The mean difference between age 
at the time of recruitment and age at the time of injury for the SA‐TEN and SA‐ATR groups was 6.9 ± 8.4 years and 
6.8 ± 8.4 years, respectively. The participants in the UK‐Achilles tendon injury cohort were matched for sex, height, 
body mass, BMI, and country of birth (Table S1). However, the age of participants at recruitment for the UK‐CON 
group (41.6 ± 11.7 years) was significantly younger than the age at the time of injury for the UK‐TEN group (45.2 ± 
14.4 years; P = .043). The participants in the UK‐TEN and UK‐ATR groups were significantly older (8.3 ± 8.6 and 10.8 
± 11.3 years) and heavier (1.6 ± 6.0 and 5.0 ± 7.3 kg) at the time of recruitment than at the time of injury. 
When the SA‐ and UK‐Achilles tendon injury cohorts were combined, only age was significantly different between 
the combined‐CON group (38.7 ± 11.5 years) and combined‐TEN group (43.2 ± 14.3 years; P < .001). On the other 
hand, the combined‐CON group weighed significantly less (75.6 ± 16.1 kg; P < .001) and demonstrated lower BMI 
ratios (24.6 ± 3.9 kg/m2; P < .001) compared to the combined‐ATR group (body mass: 84.1 ± 15.5 kg; BMI: 27.4 ± 
4.0 kg/m2) (Table S1). 
 
The participants in the SA‐ACL rupture cohort were matched for the country of birth and height (Table S2). 
However, the SA‐CONACL participants were significantly older (29.9 ± 11.8 years) at the time of recruitment 
compared to participants in the SA‐ACL group (26.0 ± 10.8 years; P = .002) and SA‐NON subgroup (26.3 ± 10.3 years; 
P = .004) at the time of injury. A significantly larger proportion of SA‐ACL cases (73%; n = 171) including those 
reporting a non-contact mechanism of injury (75.6%; n = 102) were males compared to the SA‐CONACL group (56%; 
n = 130; P < .001). Furthermore, the SA‐CONACL participants weighed significantly less (73.5 ± 14.5 kg) with a 
corresponding lower BMI  (23.8 ± 4.0 kg/m2) than the case participants in the SA‐ACL group (body mass: 80.5 ± 16.9 
kg; P < .001; BMI: 24.7 ± 5.9; P < .001) and SA‐NON subgroup (body mass: 80.4 ± 16.1 kg; P < .001; BMI: 24.7 ± 5.4; P 
< .001). These differences remained significant after adjusting for age and sex (body mass SA‐ACL: P = .002; SA‐
NON: P = 0.008; BMI SA‐ACL: P = .001; SA‐NON: P = .011). The SA‐ACL participants were 4.6 ± 8.0 years older and 1.2 
± 4.0 kg heavier at the time of recruitment than at the time of the first ACL rupture. No significant genotype effects 
on participant characteristics including age, sex, body mass, height, and BMI were noted for the three investigated 
cohorts (Table S3). 
 
 
Genotype and allele frequencies 
 
Participants with clinically diagnosed chronic AT in the SA‐ and UK‐Achilles tendon injury cohorts demonstrated 
similar genotype and allele frequency distributions for the COL1A1 rs1107946 and rs1800012 variants. Therefore, 
the genotype datasets from these cohorts were combined to increase the statistical power of this study. The 
genotype and allele frequency distributions of the rs1107946 variant did not differ significantly between the 
combined CON and TEN groups (P = .650) or the combined CON and ATR groups (P = 1.000) (Table 2). Similarly, the 
genotype frequencies for the rs1800012 variant were similarly distributed between the combined CON and TEN 
 
groups (P = 1.000) and combined CON and ATR groups (P = .106) (Table 2). Of worth noting was that no participants 
within the ATR group demonstrated the rare TT genotype. 
 
 
With respect to the SA‐ACL rupture cohort, the genotype frequencies for the rs1107946 and rs1800012 variants 
were similarly distributed between the CON and ACL groups (P = .730 and P = .605, respectively) (Table 3). In 
addition, the rs1107946 and rs1800012 variants demonstrated similar genotype frequency distributions between 
the CON group and NON subgroup (P = 1.000 and P = 1.000, respectively) (Table 3). 
 
However, an additional analysis, which involved combining results from several previously conducted studies of 
participants of European ancestry, with those presented for ACL ruptures in the current study, demonstrated the 
significant association of the rs1800012 variant with the risk of ACL ruptures.9,11,12,20 Specifically, the rs1800012 
TT genotype (TT vs GT+GG) was significantly over- represented in the group of controls (2.7%; n = 39) compared to 
the group of cases with ACL ruptures (0.98%; n = 4; P = .040; OR: 2.8; 95% CI: 1.0‐11.0) (Figure 2). Moreover, when 
CL ruptures were considered; including both ACL and posterior CL ruptures, the rs1800012 TT genotype (TT vs 
GT+GG) was similarly associated with decreased risk of injury (CON: 2.7%; CL: 0.78%; P = .003; OR: 3.8; 95% CI: 1.4‐





Inferred haplotypes were constructed using the genotype data from the two COL1A1 variants, rs1107946 (G>T) and 
rs1800012 (G>T). Unfortunately, combined haplotype analysis was not performed in this study as the raw data from 
the previously published studies were not available. With respect to the data generated in the current study, three 
allele combinations (G‐G, T‐G, and G‐T) were inferred with a frequency greater than 10% in all investigated cohorts. 
None of the participants in any of the cohorts presented with the rare T‐T inferred haplotype. There were no 
significant differences in the distribution of the three inferred COL1A1 haplotypes between the combined‐CON and 
‐TEN groups (P = .816) (Figure 3A). 
 
However, the G‐T inferred haplotype was significantly over- represented in the combined‐CON group (16%; n = 35) 
compared to the combined‐ATR group (8%; n = 4; P = .022; Haplo.score: −2.287) (Figure 3A). Conversely, none of 
the haplotypes constructed from the two investigated COL1A1 loci were significantly associated with the risk of ACL 





This study follows several published studies that have investigated the contribution of the COL1A1 rs1107946 and 
rs1800012 variants to the profile predisposing for acute and chronic musculoskeletal soft tissue injuries (Table 1). 
These specific COL1A1 variants have been highlighted as plausible candidates based on their functionality and the 
fact that the protein encoded by the COL1A1 gene is the pre-dominant fibrillar collagen in noncartilaginous 
connective tissues. 
 
With a specific focus on the studies profiling tendon and ligament injuries, emerging evidence suggests that the 
genetic signature predisposing for chronic phenotypes mapping to the COL1A1 rs1800012 locus may contrast with 
that underpinning acute phenotypes. For example, the rare rs1800012 TT genotype has frequently been associated 
with reduced risk of acute musculoskeletal soft tissue injuries including shoulder dislocations and CL ruptures, 
specifically in white populations.9,10 On the contrary, other studies have failed to demonstrate an association 






Recently, Rodas et al33 used a multivariate modeling approach to predict risk for tendinopathies in elite athletes. In 
line with the earlier case‐control genetic association studies, neither rs1800012 nor rs1107946 was identified as 
robust markers for injury prediction. 
In accordance, the current study failed to highlight a significant association with injury risk for chronic Achilles TEN 
and the investigated COL1A1 variants. However, the rs1800012 variant was associated with the risk of acute 
musculoskeletal soft tissue injuries. Specifically, the rare rs1800012 TT genotype was associated with a significant 
decrease in risk for ACL ruptures when the results from the current study were combined with previously published 
data.9,11,20 
 
Although the rs1800012 T allele is more common in the European population (19%) compared to non‐European 
populations (African: 6%, East Asian: 0%, and South Asian: 10% [www.ensembl. org]), the rs1800012 TT genotype is 
still rare. Consequently, many independent studies, especially those investigating non‐European populations, have 
been underpowered to effectively study the association of this variant with the risk of injury.17,19 In addition, the 
rare TT genotype, may also explain the lack of association in the independent SA‐ACL rupture cohort investigated in 
the current study and other studies reporting small sample sizes. Therefore, these results highlight the importance 
of testing the association of rare variants in larger cohorts, as performed in the combined analyses of this study. 
 
Besides, the independent association of the rs1800012 variant with the risk of acute musculoskeletal soft tissue 
injuries, Ficek et al11 previously described the association of the G‐T (rs1107946‐rs1800012) inferred haplotype 
with reduced risk for ACL rupture. This haplotype was similarly associated with reduced risk for acute ATR in the 
current study. However, due to the small number of participants with ATR, this result would require validation in a 
larger sample set. Although no association of the G‐T inferred haplotype was reported to alter the risk of ACL 
ruptures, it was not possible to analyze previously published haplotype data with that produced in the current 
study. 
 
In comparison to rs1800012 variant, the COL1A1 promoter variant, rs1107946, is less well characterized in the 
profiles predisposing for musculoskeletal soft tissue injuries. To the best of our knowledge, this variant has not 
been profiled for its contribution to the risk of chronic tendon and ligament injuries. Furthermore, this variant has 
demonstrated contrasting associations with ACL injuries sustained through different mechanisms. Specifically, this 
variant was not independently associated with the risk of ACL ruptures in a group of professional soccer players of 
Polish ancestry or with the risk of ACL injury in the SA‐ACL rupture cohort presented in the current study,11 yet the 
rs1107946 GG genotype was associated with increased risk for ACL ruptures sustained during skiing activities.13 
Skiers commonly present with ACL ruptures; however, the mechanisms resulting in these injuries are suggested to 
be unique to the sport. It may be proposed that external factors such as ground surface and equipment may 
influence the outcome of skiing‐associated ACL injuries to a greater degree to that of noncontact ACL ruptures 
sustained during movement on land, which are believed to occur because of an individual's own movement with no 
external perturbation. Therefore, the association of the COL1A1 rs1800012 and rs1107946 variants with the risk of 
ACL ruptures in skiers requires validation in other independent cohorts.12,13 The rs1107946 T allele has a higher 
frequency in non‐European populations (African: 31%, East Asian: 30%, and South Asian: 24%) and is, therefore, 
more informative at inferring risk in these populations compared to that in the European population for which the 
allele frequency is only 14% (www.ensembl.org). 
 
These COL1A1 variants have also been explored functionally and have been proposed to influence DNA binding, 
gene transcription, and protein production.34–36 The rs1107946 variant demonstrates allele‐dependent 
transcriptional differences with the ancestral G allele associated with a higher level of transcription compared to 
the T allele, both independently and in combination with a neighboring promoter variant, rs11327935 (indel/T).36 
Similarly, the rare 
 
rs1800012 T allele demonstrates an increased binding affinity for the Sp1 transcription factor using gel shift assays, 
in addition to demonstrating a threefold increase in the level of primary COL1A1 messenger RNA (mRNA) compared 
to the ancestral G allele.34,35 The rs1800012 T allele is also associated with a higher α1 (I) to α2 (I) collagen protein 
ratio, which reflects the increased ratio of COL1A1 mRNA relative to COL1A2 (2.3:1).34 This has been observed to 
result in the production of homotrimeric type I collagen molecules. Comparatively, type I collagen production by 
osteoblasts derived from individuals with the rs1800012 GG genotype demonstrated ratios close to the expected 
(2:1, respectively).34 Furthermore, the strength and stiffness of bone derived from rs1800012 heterozygote 
individuals were significantly lower compared with that of bone derived from individuals with the common 
rs1800012 GG genotype. 
 
Interestingly, Jin et al35 reported that the level of COL1A1 transcription is influenced by the interaction of variants 
located within 5′ regulatory region of the gene, rather than that of the individual variants, for which there were no 
consistent effects on gene transcription observed. These variant interactions were hypothesized to involve 
chromatin looping. Specifically, the COL1A1 G‐del‐T (rs1107946‐rs11327935‐rs1800012) inferred haplotype drove a 
significantly higher level of gene transcription compared to the other investigated allele combinations.35 
 
However, it must be noted that the rs1800012 and rs11327935 variants are tagged loci (D′: 1.000, r2: 1.000). 
Therefore, genotyping only one of the tagged loci as conducted in the current study is necessary. It was postulated 
that based on the effects on COL1A1 transcription and collagen type‐I chain production, the G‐del‐T inferred 
haplotype reduced bone mineral density and consequently predisposed for osteoarthritis. Interestingly, this 
haplotype appears to have the opposite effect within soft musculoskeletal tissues, as suggested by the results 
presented in the current study and that by Ficek et al,11 in which the G‐T inferred haplotype (rs1107946‐
rs1800012) was associated with decreased risk of Achilles tendon and ACL ruptures. It may be postulated that an 
increase in homotrimeric type‐I collagen molecules may increase the tensile strength of tendons and ligaments; 
thereby, reducing the risk of acute soft tissue ruptures. 
 
In conclusion, this study contributes to the growing body of evidence implicating the COL1A1 Sp1 binding site 
variant in the genetic profile predisposing for acute musculoskeletal soft tissue injuries, specifically ACL ruptures. 
This study also provided evidence for the association of the COL1A1 G‐T inferred haplotype (rs1107946‐rs1800012) 
with the risk of ATR. This is the same haplotype previously associated with the risk of ACL ruptures. Moreover, this 
research has reiterated the heterogeneity of musculoskeletal soft tissue injuries whereby some loci predisposing for 
acute musculoskeletal soft tissue injuries may not necessarily be informative risk markers for chronic phenotypes. 
To understand the biological mechanisms underpinning these risk associations, it is important that we begin to 
explore the effects of these markers on the mechanical properties of the tissue. This is more likely achievable with 
the pooling of resources and expertise, in addition to the sharing of omics data generated through the use of next‐
generation sequencing technologies.37 Lastly, with the generation of more genomic data, researchers should aim 
to develop integrative multi- variate models; expeditions which are more likely to reveal robust risk conferring 
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